Duke University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Duke University sits in the top decile of US sponsors by registered trial count (#9 of 15,742 sponsors by registered trial count).
Duke University: 1,725 sponsored US clinical trials, 187 recruiting.
Duke University sponsors 1,725 registered US clinical trials on ClinicalTrials.gov, 187 of them currently recruiting, and 1,244 completed. 175 of these trials are in Phase 3-4 (later-stage) and 311 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 15 trials.
Top-decile sponsor footprint
Duke University ranks in the top decile of sponsors by registered trial count (#9 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
1,244 of 1,444 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (86.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,725 total, page 22 of 35
An Observational Study of Post-cesarean Delivery Respiratory Patterns Using a Non-invasive Minute Ventilation Monitor (Exspiron ™ System)
NCT02903173
Novel Biomarker for Development of T2D
NCT02326129
Feasibility Testing of the Quality-monitoring Tool, Qdact, for the Palliative Care Research Cooperative
NCT02411305
Message Framing and Colorectal Cancer Screening
NCT02483832
Obstructive Sleep Apnea in Pregnancy
NCT02383706
Hyperbaric VO2max Study
NCT02356900
Efficacy and Safety of Low Amplitude Electroconvulsive Therapy
NCT02351843
The Use of a Dynamic Compression Intramedullary Nail for Tibiotalocalcaneal Arthrodesis
NCT02324907
Treatment for Teens With Alcohol Abuse and Depression
NCT02227589
The Effects of Potassium on Glucose Metabolism in African Americans
NCT02236598
Nonconvulsive Seizure Identification on Quantitative EEG by Neuro ICU Nurses
NCT02082873
PEACE: Pediatric Antifungal Comparative Effectiveness
NCT01869829
Evaluating CVD Medication Adherence Program in Low SES
NCT02375737
BIOPIC: Fungal Biomarkers for Diagnosis and Response to Therapy for Pediatric Candidemia
NCT02220790
TXA vs. Amicar in Total Knee and Hip Arthroplasty
NCT02030821
Infant Immunity Comparison of Breastfed and Bottlefed Infants
NCT02568579
Mobile Contingency Management for Smoking Cessation in Returning US Veterans
NCT02513069
Virtual Reality for Osteoarthritis Knee Pain Pilot
NCT01899508
Study of High-dose Spironolactone vs. Placebo Therapy in Acute Heart Failure
NCT02235077
Determine the Prevalence and Severity of Asthma in HIV (Human Immunodeficiency Virus) Infected Patients
NCT02405026
Reducing Pain of Lidocaine Injection
NCT02288364
Neovascular Morphology and Persistent Disease Activity Among Patients With NV AMD
NCT02367365
Effect of Feedings on Caffeine in Premature Infants
NCT02293824
Intra-Arterial Microdosing: Proof-of-Concept in Humans
NCT02304211
Dexamethasone and Pain Following Total Knee Arthroplasty
NCT02271698
SDOCT-GMPE Software
NCT02235454
Function and Scoliosis Surgery
NCT02237248
Molecular Mechanisms Underlying Prostate Cancer Disparities
NCT02229565
Temperature Monitoring With InnerSense Esophageal Temperature Sensor/Feeding Tube After Birth Through Stabilization in VLBW Infants
NCT02311972
Depression and Heart Failure Disease Progression
NCT02131428
Patient-Reported Preferences Affecting Revascularization Decisions
NCT02272062
Effect of Tourniquet on Sensory Nerve Conduction Threshold (sNCT) and OxyNeuroGram (ONG) Index- A Volunteer Study
NCT01970839
Effects of Chemoradiation and Surgery on Cardiopulmonary Fitness and Tumor Neoplastic Phenotype in Gastrointestinal Malignancies
NCT02235441
Whole Eye Optical Coherence Tomography (OCT) to Improve Refractive Surgery and Eye Care
NCT03219567
Mobile Pain Coping Skills Training for Cancer Pain
NCT02266017
Contingency Management, Quitting Smoking, and ADHD
NCT02266784
Effects of Smoking Environment on Craving and Smoking
NCT02416986
Hepatitis C Alcohol Reduction Treatment
NCT02176980
mHealth Messages to Sustain Recent Weight Loss - Phase 2
NCT02279017
Monocyte Phenotypic and Functional Differences
NCT02132182
Medical Home Care for Hematopoietic Stem Cell Transplantation Phase 2
NCT02218151
Effects of Exercise and Improved Nitric Oxide Bioavailability on Arteriovenous Fistula Maturation
NCT02164318
Self-management Interventions for Advanced Breast Cancer
NCT01927081
Comparison of Topical Skin Adhesive to Subcuticular Suture Closure of Implantable Port Incisions
NCT02212977
Respiratory Viral Infections in Pediatric Transplantation
NCT02260596
The Effect of Prophylactic Antipyretics on Immune Responses and Fever After 2014-2015 and 2015-2016 Inactivated Influenza Vaccine
NCT02212990
Healthy Lifestyles Program for You (HLP4U): Augmenting Childhood Obesity Treatment.
NCT01989065
Improving Memory Performance by Applying Cognitive Training
NCT02216591
Integrative Health Coaching in Community Settings
NCT02186327
Safety Study of Regorafenib With PF-03446962 to Treat Colorectal Cancer
NCT02116894
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 136 |
| Phase 2 | 175 |
| Phase 3 | 41 |
| Phase 4 | 134 |
Therapeutic Areas
What is open in the Duke University pipeline
187 recruiting of 1,725 indexed (11% open); 1,244 completed (72%).
Phase mix: 175 late (III/IV) vs 311 early (I/II) (early-phase heavy).
Top condition: Obesity (15 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Duke University: open-pipeline peers nationwide
Peers matched on 1,725 registered trials and 11% open enrollment, not the therapeutic-area sidebar.
Duke University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,725 trials (± recruiting share)
- University of California, San Francisco · 1,713 trials · 16% recruiting
- Stanford University · 1,744 trials · 15% recruiting
- VA Office of Research and Development · 1,668 trials · 17% recruiting
- Pfizer · 1,845 trials · 6% recruiting
Sponsors near 11% open enrollment (± trial volume)
- Carnegie Mellon University · 11% recruiting · 37 trials
- CAMC Health System · 11% recruiting · 28 trials
- UConn Health · 11% recruiting · 178 trials
- Hartford Hospital · 11% recruiting · 75 trials
Related
What to do with this Duke University page
1,725 registered trials is a research-attention snapshot, not an endorsement of Duke University or any single study.
- 187 of Duke University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition Duke University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Duke University pipeline card: 1,725 registered trials from official public datasets.Report a data error.